FindTrial
Sign In

Neutrophil Extracellular Traps as a Biomarker to Predict Portal Vein Tumor Thrombosis in Patients With Hepatocellular Carcinoma

Neutrophil Extracellular Traps as a Biomarker to Predict Portal Vein Tumor Thrombosis in Patients With Hepatocellular Carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100050233
Enrollment
Unknown
Registered
2021-08-24
Start date
2021-09-01
Completion date
Unknown
Last updated
2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

portal vein tumor thrombosis in patients with HCC

Interventions

PVTT group:Nil
HCC?:Nil
control group:Nil

Sponsors

The Affiliated Hospital of Qingdao University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Clinical diagnosis of HCC with liver cirhosis; 2. Clinical diagnosis of portal vein tumor thrombosis.

Exclusion criteria

Exclusion criteria: 1. Secondary liver malignancy; 2. Hematologic diseases; 3. Bud-Chiah syndrome; 4. Incomplete data.

Design outcomes

Primary

MeasureTime frame
neutrophil extracellular traps;—

Secondary

MeasureTime frame
anti-beta GPI;—

Countries

China

Contacts

Public ContactJing Xue

The Affiliated Hospital of Qingdao University

jingxue@qdu.edu.cn+86 18661807575

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026